Security key
53271X116
Liminatus Pharma, Inc. - *W EXP 04/30/203 (LIMNW)
CUSIP: 53271X116
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / *W EXP 04/30/203
- Total 13F shares
- 35,416
- Total 13F value
- $1,960
- Share change
- 0
- SEC-reported price per share
- $0.06
- Number of holders
- 2
Report period
Q3 2026
Institutions
2
Top holders
2
LIMNW full security history
Ownership snapshot
Full 13F holder table
Liminatus Pharma, Inc. SEC filings
Liminatus Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53271X116
Recent filing periods:
Ownership snapshot
Top reported holders of LIMNW - Liminatus Pharma, Inc. - *W EXP 04/30/203 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Iris Acquisition Holdings...
Disclosed value leader
Valetudo Therapeutics LLC
Comparable rows
8/15
Latest evidence
02 Jul 2026
3/4/5
13D/G
13F
Lead comparable stake: 26%
7 rows are not safely comparable across share classes.
13D/G row: Iris Acquisition Holdings LLC
Showing 1-6 of 15 holder rows.
Quick read
Iris Acquisition Holdings LLC leads the comparable SEC ownership view at 26%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Iris Acquisition Holdings LLC's linked filing trail.
Comparable ownership
Top 5
Iris Acquisition Holdings LLC
26%
KH Feelux Co., Ltd
15%
Valetudo Therapeutics LLC
14%
Ewon Comfortech Co., Ltd.
11%
Apple Association 1st Nongae
5.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Iris Acquisition Holdings LLC |
3/4/5
13D/G
10%+ Owner
|
26%
Reported 13D/G
· 30 Apr 2025
|
$45,885,000
6,900,000 shares
|
— | 30 Apr 2025 |
| KH Feelux Co., Ltd |
3/4/5
13D/G
10%+ Owner
|
15%
Reported 13D/G
· 30 Apr 2025
|
$20,880,000
4,000,000 shares
|
— | 30 Apr 2025 |
| Valetudo Therapeutics LLC |
3/4/5
13D/G
10%+ Owner
|
14%
Reported 13D/G
· 02 Jul 2026
|
$69,466,653
5,293,326 shares
mixed-class rows
|
— | 02 Jul 2026 |
| Ewon Comfortech Co., Ltd. |
3/4/5
13D/G
10%+ Owner
|
11%
Reported 13D/G
· 24 Jun 2026
|
$945,450
5,500,000 shares
|
— | 24 Jun 2026 |
| Apple Association 1st Nongae |
13D/G
Nongae Apple Association 1st
|
5.7%
Reported 13D/G
· 30 Apr 2025
|
$7,673,400
1,470,000 shares
|
$0 | 30 Apr 2025 |
| Peony Association 1st Red |
13D/G
Red Peony Association 1st
|
5.7%
Reported 13D/G
· 30 Apr 2025
|
$7,673,400
1,470,000 shares
|
$0 | 30 Apr 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
35,416
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
22
Q3 2026 holders
2
Holder diff
-20
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend